Virta Health: $1.3B valuation, IPO Readiness 66, Series F. Clinically-proven program reversing type 2 diabetes through continuous remote care and nutrition. Track live on The IPO Stack.
Clinically-proven program reversing type 2 diabetes through continuous remote care and nutrition.
Scores, valuations, and IPO signals for the companies that matter. 5-minute read, every Tuesday.
Top companies most likely to IPO in 2026, ranked by IPO Readiness Score.
Track Virta Health IPO timeline, funding rounds, investor activity, and valuation on TechStackIPO — the pre-IPO intelligence platform.
Virta Health has not announced a specific IPO date as of 2026. Track TechStackIPO for the latest funding milestones and IPO signals. Subscribe to The IPO Stack newsletter for weekly updates.
Virta Health is valued at $1.3B as of December 2021. This valuation is based on its most recent private funding round tracked by TechStackIPO.
Accredited investors can access Virta Health shares through secondary market platforms, pre-IPO investment funds, and broker-dealer platforms that facilitate private company transactions. TechStackIPO's marketplace tracks available access options. Note: pre-IPO investments carry higher risk and limited liquidity compared to public market investing.
Virta Health scores 66/100 (Grade: C) on TechStackIPO's IPO Readiness Index. The score evaluates funding scale, valuation trajectory, funding momentum, stage progression, and company maturity. Scores above 70 indicate strong near-term IPO potential.
Virta Health has raised $523M in total venture capital and private equity funding, with backing from Tiger Global, General Atlantic, Sequoia Capital.
Virta Health's notable investors include Tiger Global, General Atlantic, Sequoia Capital, Caffeinated Capital, Venrock. Full investor details, funding round history, and lead investor breakdowns are available on TechStackIPO.
Virta Health is a Healthcare Technology company. Clinically-proven program reversing type 2 diabetes through continuous remote care and nutrition.